Skip to main content
. Author manuscript; available in PMC: 2021 Nov 2.
Published in final edited form as: Lupus. 2021 Jul 20;30(11):1747–1755. doi: 10.1177/09612033211033981

Table 1.

Baseline Characteristics of Study Participants

Characteristic Participants
(n = 63)
Age: mean ± SD years (range) 42.5 ± 13.5 (21.0 – 78.0)
Female: n (%) 62 (98.4)
Race: n (%)
 White 31 (49.2)
 Black 15 (23.8)
 Asian 9 (14.3)
 More than One Race 5 (7.9)
 Not Reported 3 (4.8)
Ethnicity: n (%)
 Hispanic/Latino 10 (15.9)
Insurance: n (%)
 Medicaid 14 (22.2)
 Medicare 7 (11.1)
 Commercial 42 (66.7)
On Disability (by patient self-report): n (%) 17 (27.0)
Geographic Location: n (%)
 Boston 23 (36.5)
 New York 40 (63.5)
SLE Characteristics
SLE Disease Duration: mean ± SD years (range) 10.9 ± 9.2 (0.5 – 44)
SELENA-SLEDAI: mean ± SD (range) [Range 0 to 105, higher worse] 3.3 ± 3.3 (0 – 14)
SLICC/ACR Damage Index: mean ± SD (range) [Range 0 to 46, higher worse] 1.0 ± 2.0 (0 – 13)
Co-Morbid Conditions (by patient self-report)
Anxiety: n (%) 14 (22.2)
Depression: n (%) 13 (20.6)
Fibromyalgia: n (%) 11 (17.5)